Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Click for "last 6 years' i10 index". Also see: Universities Rankings 2024 (Sort by : Total i10 Index) and Universities Rankings 2024 (Sort by : Last 6 Years i10 Index)
Total i10 Index | AD Scientific Index - World Scientists i10 Productivity Rankings - 2024 | i10 Index Metrics | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
University Rank | Country Rank | Region Rank | World Rank | Name | Country | University / Institution |
Subject Research Areas |
Total | Last 6 Year | Last 6 year/total |
2 | 431 | 9,267 | 26,391 | Switzerland | Roche |
Others
lung cancer | |
217 | 177 | 0.816 | |
39 | 2,602 | 2,824 | 51,821 | Australia | Flinders University |
Others
|
156 | 77 | 0.494 | |
5 | 1,406 | 34,407 | 95,229 | Switzerland | Roche |
Others
muscle | muscular dystrophy | motor neuron disease | neuromuscular | |
109 | 96 | 0.881 | |
55 | 33,597 | 38,335 | 109,899 | United States | National Cancer Institute |
Others
|
100 | 60 | 0.600 | |
9 | 1,615 | 40,017 | 110,181 | Switzerland | Roche |
Others
Disease Modeling | Biophysics | Pharmacokinetics | Pharmacodynamics | Ocular and Transdermal Drug Delivery | |
100 | 48 | 0.480 | |
11 | 1,674 | 42,057 | 115,710 | Switzerland | Roche |
Others
Real world evidence | pharmacoepidemiology | observational research | drug development | evidence synthesis | |
96 | 94 | 0.979 | |
12 | 36,380 | 41,506 | 119,762 | United States | National Institute of Neurological Disorders and Stroke |
Others
|
94 | 79 | 0.840 | |
33 | 3,512 | 45,834 | 125,965 | France | Institut Pierre-Simon Laplace |
Others
|
91 | 69 | 0.758 | |
15 | 1,897 | 49,656 | 136,006 | Switzerland | Roche |
Others
Neurodegeneration | Imaging | Parkinson | PET | |
86 | 81 | 0.942 | |
17 | 1,910 | 50,024 | 137,006 | Switzerland | Roche |
Others
|
86 | 61 | 0.709 | |
Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages |
||||||||||
8 | 4,290 | 53,949 | 147,581 | France | STMicroelectronics Pvt Ltd |
Others
nanotechnologies | spatial | ultra-low power | safety automotive | |
82 | 32 | 0.390 | |
20 | 2,148 | 58,193 | 159,203 | Switzerland | Roche |
Others
Drug Design | |
77 | 62 | 0.805 | |
22 | 2,180 | 59,600 | 162,973 | Switzerland | Roche |
Others
|
76 | 47 | 0.618 | |
23 | 2,248 | 61,836 | 168,857 | Switzerland | Roche |
Others
Neurodegeneration | Imaging | Fluid biomarkers | |
74 | 46 | 0.622 | |
24 | 2,305 | 64,561 | 175,954 | Switzerland | Roche |
Others
|
72 | 31 | 0.431 | |
29 | 2,723 | 79,114 | 215,306 | Switzerland | Roche |
Others
|
61 | 49 | 0.803 | |
30 | 2,741 | 79,642 | 216,720 | Switzerland | Roche |
Others
|
61 | 37 | 0.607 | |
31 | 2,752 | 80,232 | 218,291 | Switzerland | Roche |
Others
|
60 | 58 | 0.967 | |
674 | 8,809 | 71,388 | 219,083 | Canada | McGill University |
Others
open science | data science & RDM | reproducibility | metascience | animal behaviour & | |
60 | 53 | 0.883 | |
36 | 2,952 | 88,361 | 240,414 | Switzerland | Roche |
Others
|
56 | 33 | 0.589 | |
39 | 3,164 | 96,350 | 262,033 | Switzerland | Roche |
Others
|
52 | 32 | 0.615 | |
348 | 10,701 | 87,391 | 274,846 | Canada | Université Laval |
Others
GIS | GIScience | Géomatique | Geospatial Science | Smart City | |
50 | 25 | 0.500 | |
85 | 8,963 | 103,417 | 280,821 | France | Géosciences Montpellier |
Others
|
49 | 27 | 0.551 | |
40 | 3,389 | 105,090 | 285,323 | Switzerland | Roche |
Others
Drug Design | Discovery and Development | PK/PD and preclinical Safety | |
48 | 36 | 0.750 | |
42 | 3,422 | 106,758 | 289,520 | Switzerland | Roche |
Others
|
47 | 44 | 0.936 |